These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 63150)

  • 41. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrent deep venous thrombosis in pregnancy.
    Klein K; Pauker SG
    Med Decis Making; 1982; 2(2):249-51. PubMed ID: 7167051
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of venous thrombosis in antithrombin III deficient patients with concentrates of antithrombin III.
    Winter JH; Fenech A; Mackie M; Bennett B; Douglas AS
    Clin Lab Haematol; 1982; 4(2):101-8. PubMed ID: 7116792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pregnant antithrombin III deficient patient: management without antithrombin III concentrate.
    Blondel-Hill E; Mant MJ
    Thromb Res; 1992 Jan; 65(2):193-8. PubMed ID: 1579895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antithrombin III deficiency and tendency to thrombosis (author's transl)].
    Lechner K; Thaler E; Niessner H; Nowotny C; Partsch H
    Wien Klin Wochenschr; 1977 Apr; 89(7):215-22. PubMed ID: 857429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hereditary antithrombin deficiency and pregnancy. Pregnancy course in six women with known hereditary antithrombin deficiency].
    Mohapeloa HL; Wellnitz H; Laursen B
    Ugeskr Laeger; 1998 Nov; 160(49):7130-4. PubMed ID: 9850619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of venous thromboembolism.
    Ginsberg JS
    N Engl J Med; 1996 Dec; 335(24):1816-28. PubMed ID: 8943165
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticoagulation during pregnancy.
    Pabinger I; Grafenhofer H
    Semin Thromb Hemost; 2003 Dec; 29(6):633-8. PubMed ID: 14719179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inherited thrombophilia and pregnancy: the obstetric perspective.
    Bonnar J; Green R; Norris L
    Semin Thromb Hemost; 1998; 24 Suppl 1():49-53. PubMed ID: 9840692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks--the difference the dose makes.
    McLintock C
    Thromb Res; 2013 Jan; 131 Suppl 1():S8-10. PubMed ID: 23452748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticoagulants during pregnancy.
    Corbett JV; Kenney C
    MCN Am J Matern Child Nurs; 1995; 20(1):56. PubMed ID: 8756075
    [No Abstract]   [Full Text] [Related]  

  • 53. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex].
    von Felten A
    Ther Umsch; 1992 Dec; 49(12):837-42. PubMed ID: 1485282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hereditary antithrombin III deficiency. Report of an obstetric case and review of the literature].
    Leal-Tijerina G; Alvarado-Barrientos M; Sosa-Gillaumin A
    Ginecol Obstet Mex; 1996 Apr; 64():177-83. PubMed ID: 8698247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thromboembolism in pregnancy.
    Ramsay DM
    Obstet Gynecol; 1975 Feb; 45(2):129-32. PubMed ID: 1078885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
    Toulon P; Vitoux JF; Fiessinger JN; Sicard D; Aiach M
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):435-9. PubMed ID: 1718466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement treatment.
    Sánchez J; Velasco F; Alvarez R; Román J; Torres A
    Acta Paediatr; 1996 Feb; 85(2):245-7. PubMed ID: 8640060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
    Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.